Financials

  • Market Capitalization 1.82 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-8.74
Price to sales ratio
941.13

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2048
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.77 USD-3.19%-4.15%+2.85%+98.97%1.88 B USD
2065
VIR
Vir Biotechnology, Inc. - Common Stock
10.83 USD-4.24%+11.19%+25.78%+81.10%1.83 B USD
2071
SEPN
Septerna, Inc. - Common Stock
38.91 USD-3.85%-3.31%+14.44%+76.78%1.82 B USD
2076
NTLA
Intellia Therapeutics, Inc. - Common Stock
12.87 USD-1.83%+2.14%+17.97%-6.20%1.80 B USD

Frequently asked questions about Inhibrx Biosciences, Inc. Common Stock

What is the Inhibrx Biosciences, Inc. Common Stock stock price today?

The current price of Inhibrx Biosciences, Inc. Common Stock (INBX) is 123.41. Over the past 24 hours, the stock has changed by -0.42%. Follow the INBX chart for real-time price dynamics.

What is the stock ticker of Inhibrx Biosciences, Inc. Common Stock?

Inhibrx Biosciences, Inc. Common Stock trades under the ticker INBX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Inhibrx Biosciences, Inc. Common Stock stock going up?

INBX has changed by +17.53% over the last week, +52.34% over the last month, and +53.15% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Inhibrx Biosciences, Inc. Common Stock?

Inhibrx Biosciences, Inc. Common Stock currently has a market capitalization of 1.82 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Inhibrx Biosciences, Inc. Common Stock earnings last quarter?

Last quarter, Inhibrx Biosciences, Inc. Common Stock reported earnings of -2.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Inhibrx Biosciences, Inc. Common Stock revenue for the last quarter?

Inhibrx Biosciences, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Inhibrx Biosciences, Inc. Common Stock net income for the last quarter?

Inhibrx Biosciences, Inc. Common Stock reported net income of -36.65 M for the last quarter. The previous quarter showed -33.44 M, which means net income changed by -9.60%.

How many employees does Inhibrx Biosciences, Inc. Common Stock have?

As of the latest available data, Inhibrx Biosciences, Inc. Common Stock has 110 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Inhibrx Biosciences, Inc. Common Stock stock?

You can buy Inhibrx Biosciences, Inc. Common Stock (INBX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Inhibrx Biosciences, Inc. Common Stock stock?

Investing in Inhibrx Biosciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INBX chart and related analysis on metatrader.com as part of your research.

News